Skip to main content

Table 5 Changes in the proportion of high-risk individuals with and without diabetes achieving the targets between the initial and one year assessments

From: Comparison of treatment outcomes in patients with and without diabetes mellitus attending a multidisciplinary cardiovascular prevention programme (a retrospective analysis of the EUROACTION trial)

 

DM

NON-DM

 

IA

1 year

Diff %

P value

IA

1 year

Diff %

P value

Not smoking

261/316 (82.6)

270/316 (85.4)

2.8%

0.035

455/703 (64.7)

479/703 (68.1)

3.4%

0.0003

Oily fish target

17/312 (5.4)

29/312 (9.3)

3.8%

0.008

34/700 (4.9)

84/700 (12.0)

7.1%

<0.001

Fish target

214/333 (62.3)

256/333 (76.9)

12.6%

<0.001

457/764 (59.8)

561/764 (73.4)

13.6%

<0.001

F/V target

190/316 (60.1)

262/316 (82.9)

22.7%

<0.001

329/703 (46.8)

532/703 (75.7)

28.9%

<0.001

PA target

95/312 (30.4)

206/312 (66.0)

35.6%

<0.001

205/698 (29.4)

536/698 (76.8)

47.4%

0.002

Mean Steps/day

6185

7294

1109

<0.001

6900

7984

1084

<0.001

Ideal WC Females

8/158 (5.1)

13/158 (8.2)

3.2%

0.025

83/338 (24.6)

97/338 (28.7)

4.1%

0.029

Ideal WC Males

30/146 (20.5)

39/146 (26.7)

6.2%

0.023

133/353 (37.7)

155/353 (43.9)

6.2%

0.005

BMI target

24/312 (7.7)

31/312 (9.9)

2.2%

0.06

169/697 (24.2)

196/697 (28.1)

3.9%

0.0001

Mean weight

83.6

82.5

−1.1

<0.001

78.7

77.6

−1.1

<0.001

Mean TC

5.48

5.11

−0.37

<0.001

6.14

5.63

−0.5

<0.001

Mean LDL

3.28

2.9

−0.38

<0.001

3.85

3.43

−0.42

<0.001

Mean SBP

140.6

133.9

−6.7

<0.001

141.4

133.6

−7.8

<0.001

Mean DBP

81.6

77.9

−3.7

<0.001

85.6

81.3

−4.2

<0.001

TC target

82/295 (27.8)

143/295 (48.5)

20.7%

<0.001

63/672 (9.4)

152/672 (22.6)

13.2%

<0.001

LDL target

93/274 (33.9)

157/271 (57.3)

23.4%

<0.001

96/652 (14.7)

196/652 (30.1)

15.3%

<0.001

BP target (<130/85 DM; <140/90 Non-DM)

76/311 (24.4)

120/311 (38.6)

14.1%

<0.001

286/698 (40.9)

467/698 (66.9)

25.9%

<0.001

Mean HbA1c

6.6

6.4

0.20

0.002

n/a

n/a

n/a

n/a

BB

62/129 (48.0)

62/129 (48.0)

0%

1.000

77/496 (15.5)

99/496 (19.9)

4.4%

0.0002

ACEI/ARB

128/184 (69.6)

131/184 (71.2)

1.6%

0.508

142/517 (27.5)

203/517 (39.3)

11.8%

<0.001

Anti-platelet

32/111 (28.8)

40/111 (36.0)

7.2%

0.008

50/483 (10.3)

71/483 (14.7)

4.3%

<0.001

Statins

73/164 (44.5)

102/164 (62.2)

17.7%

<0.001

77/542 (14.2)

200/542 (36.9)

22.7%

<0.001

  1. Data are proportion as a percentage % (of the numbers in each group who had both IA and one year data for the variables in question) and percent difference between IA and one year; ACEI/ARB- angiotensin converting enzyme inhibitor/angiotensin receptor blocker; BB- beta blocker; BMI- body mass index; CCB- calcium channel blocker; DBP- diastolic blood pressure; LDL- low density lipoprotein cholesterol; n/a- not applicable; SBP- systolic blood pressure; SF- saturated fat; TC- total cholesterol; TG- triglyceride.
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us